• Passa al contenuto principale
BC

biochimica clinica

it_IT Italian
it_IT Italian en_US English
  • Home
  • Casi clinici
  • Ahead of print e Ultimo Fascicolo - Accedi per visualizzare gli articoli
  • Archivio BC fino a 2024
  • Sottometti un articolo
  • Norme Autori
  • Cerca

CASI CLINICI – Case Reports

Volume:

Biochimica Clinica, 2024; 48(1) e10-e12

Pubblicato on-line:

Dicembre 21, 2023

DOI:

10.19186/BC_2023.092

Scarica in PDF:
Autenticazione richiesta

Cavernous blood gas analysis in the diagnosis of priapism

AUTORI

Gema García-de la Rosa, Ruth López-Travieso
Hospital U. Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain

ABSTRACT

Cavernous blood gas analysis in the diagnosis of priapism

The significance of blood gas analysis in the rapid and accurate diagnosis of priapism, enabling the distinction between low-flow and high-flow types deserves to be highlighted. It is a valuable tool in the clinical setting to guide timely intervention, especially in emergencies, and enhance patient outcomes, thereby reducing the risk of complications such as erectile dysfunction and penile fibrosis. We present a case of a 69-year-old male patient who developed priapism. Cavernosal blood gas analysis provided conclusive evidence of low-flow priapism, confirming veno-occlusive pathophysiology based on abnormal pH, pO2 and pCO2 values. The patient underwent venous blood aspiration from the corpora cavernosa, leading to complete penile detumescence and rapid resolution of the priapism. Laboratory medicine, through the analysis of cavernous blood gases, plays a pivotal role in accelerating the diagnostic path and the clinical management of priapism.

BIBLIOGRAFIA

1. Ericson C, Baird B, Broderick GA. Management of priapism: 2021 Update. Urol Clin North Am 2021;48:565-76.
2. Eland IA, van der Lei J, Stricker BH, Sturkenboom MJ. Incidence of priapism in the general population. Urology 2001;57:970-2.
3. Roghmann F, Becker A, Sammon JD, Ouerghi M, Sun M, Sukumar S, et al. Incidence of priapism in emergency departments in the United States. J Urol 2013;190:1275.
4. Broderick GA, Kadioglu A, Bivalacqua TJ, Ghanem H, Nehra A, Shamloul R, et al. Priapism: pathogenesis, epidemiology, and management. J Sex Med 2010;7:476-500.
5. Capece M, La Rocca R, Mirone V, Bivalacqua TJ, Castiglione F, Albersen M, et al. A systematic review on ischemic priapism and immediate implantation: do we need more data? Sex Med Rev 2019;7:530-4.
6. Adams LA, Evans DD. Management of priapism in the emergency department. Adv Emerg Nurs J 2022;44:121-6.
7. Partin AW, Peters CA, Kavoussi LR, Dmochowski RR, Wein AJ, eds. Campbell-Walsh-Wein Urology 12th Edition Review. Amsterdam:Elsevier, 2020.
8. Salonia A, Eardley I, Giuliano F, Hatzichristou D, Moncada I, Vardi Y, et al. European Association of Urology guidelines on priapism. Eur Urol 2014;65:480-9.
9. Montague DK, Jarow J, Broderick GA, Dmochowski RR, Heaton JPW, Lue TF, et al. American Urological Association guideline on the management of priapism. J Urol 2003;170:1318-24.

HOME
PRIVACY POLICY
5x1000 Docemus

LOGO SIBioC

EDITORE RESPONSABILE
Alberto Oliaro

EDITORIAL SECRETARY
Edizioni Minerva Medica S.p.A.
Corso Bramante 83-85, 10126 Torino
T +39 011 678282
journals.dept@minervamedica.it

Designed by Biomedia srl
© 2025 SIBioC
P. IVA IT 06484860967